Paroxetine treatment of generalized anxiety disorder.

Oct 21, 2003Psychopharmacology bulletin

Paroxetine treatment for generalized anxiety disorder

AI simplified

Abstract

Generalized anxiety disorder (GAD) is believed to affect at least 5% of the general population.

  • GAD is characterized by chronic and uncontrollable worry, anxiety, and tension.
  • These symptoms can hinder social, professional, and family roles.
  • Effective pharmacologic treatments should have both anxiolytic and antidepressive properties due to high comorbidity with other psychiatric disorders.
  • Paroxetine is the best studied SSRI for GAD and is the only one approved by the US Food and Drug Administration for this condition.
  • Randomized controlled studies indicate that paroxetine is effective for the short-term treatment of GAD and can help achieve and sustain full remission.

AI simplified

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free